Atreca, Inc.
USD0.09
-0.00 (-1.32%)
CEO
John A. Orwin
IPO Date
2019-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.09
Prev. Close
$0.09
Day Low
$0.09
Day High
$0.09
52W Low
$0.05
52W High
$1.20
Market Cap
$0.00B
Volume
0.12M
| -1.0 |
| 31 Dec 2020 | FY | 0.0% | -6381.0% | -35.7% | -31.7% | 0.00 | 14.30 | -6.0 |
| 31 Dec 2019 | FY | 0.0% | -3162.3% | -36.1% | -34.5% | 0.00 | 22.16 | -3.6 |
| 31 Dec 2018 | FY | 0.0% | -3948.0% | -32.4% | -31.2% | 0.00 | 25.70 | -1.5 |
| 31 Dec 2017 | FY | 0.0% | -1601.3% | 48.7% | -76.2% | -0.00 | 11.66 | -1.5 |
| -0.5 |
| 31 Mar 2023 | Q1 | -1778.3% | -22837.0% | -34.5% | -15.6% | 1.03 | 4.24 | -0.5 |
| 31 Dec 2022 | Q4 | -8915.0% | -106725.0% | -27.2% | -13.8% | 0.81 | 4.79 | -0.4 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -24.0% | -13.4% | 0.67 | 6.37 | -0.7 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -24.2% | -14.6% | 0.57 | 8.14 | -0.6 |
| 31 Mar 2022 | Q1 | -131.7% | -3322.7% | -18.1% | -11.7% | 0.48 | 9.57 | -1.2 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -19.1% | -14.8% | 0.00 | 7.24 | -1.0 |
| 30 Sept 2021 | Q3 | 0.0% | -17315.2% | -15.6% | -12.4% | 0.00 | 10.03 | -2.1 |
| 30 Jun 2021 | Q2 | 0.0% | -7643.3% | -13.4% | -11.1% | 0.00 | 13.48 | -2.9 |